関連する実験動画
Updated: Jan 6, 2026
01:19
Mitral Valve Prolapse III: Nursing Management
Published on: June 19, 2025
252
VEGFが誘発した血管透過性の病理生理学的影響
1Department of Pathology and Moores UCSD Cancer Center, University of California, San Diego, La Jolla, California 92093-0803, USA.
Nature
|September 24, 2005
まとめ
血管内皮成長因子 (VEGF) は血管の成長を促すだけでなく,血管の透過性を高めます. VEGFをブロックする
科学分野:
- 心血管生物学 心血管生物学
- 腫瘍学 腫瘍学
- 神経科学は神経科学である.
背景:
- 血管内皮成長因子 (VEGF) は血管新生に不可欠です.
- VEGFは,病理的な状態において,血管壁の整合性を破壊する.
- この障害は組織損傷と疾患の進行につながります.
研究 の 目的:
- 血管新生と血管の透過性におけるVEGFの二重の役割を調査する.
- VEGFによって引き起こされる血管漏れの病理生理学的結果を調査する.
- VEGFの血管透過性効果を抑制する治療の可能性を評価する.
主な方法:
- VEGFが内皮細胞と細胞の結合に及ぼす影響の分析.
- 缺血性疾患およびがんのモデルにおけるVEGF誘発の血管浸透性の検討.
- VEGF媒介の血管漏れを標的とした治療戦略の評価.
主要な成果:
- VEGFは内皮細胞を分離し,血管の透過性と腫れを増加させます.
- VEGF誘発の血管漏れは,脳卒中や心筋梗塞などの不全性疾患における組織損傷を悪化させる.
- VEGFは腫瘍細胞の拡張を高め,転移を促進する可能性があります.
結論:
- VEGFの血管浸透性の効果をターゲットにすることは,潜在的な治療戦略を提供します.
- VEGF誘発の漏れを抑制することで,不全性疾患における組織損傷を減らすことができる.
- VEGFをブロックすると,癌の転移を制限する可能性があります.
関連する概念動画
Mitral Valve Prolapse III: Nursing Management
252
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
252
Cancer Vaccines
917
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
917
Development of Immunocompetence
759
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
759
Vaccinations
51.1K
Overview
51.1K
Healthcare Associated Infections II: Preventive Measures
3.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
3.5K
Teratogenicity
3.9K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.9K